Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1973 Jun;14(2):153–158.

Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis

Elizabeth A Calder, W J Penhale, Dena McLeman, E W Barnes, W J Irvine
PMCID: PMC1553786  PMID: 4740445

Abstract

In the presence of normal human lymphocytes, decomplemented sera from twentynine out of thirty-nine patients with Hashimoto thyroiditis caused significant lysis of thyroglobulin-coated chicken red blood cells, as estimated by the release of 51Cr; the mean% specific 51Cr release being 14·1 ± 1·9 (SEM). Serum from twenty-one control subjects studied concurrently caused no significant lysis of thyroglobulin-coated chicken red blood cells; the mean% specific 51Cr release being −1·6±0·7 (SEM).

The degree of cytotoxicity correlated with the titre of thyroglobulin antibodies in the serum, determined by tanned red cell haemagglutination. The active component in the Hashimoto serum was localized in the 19S fraction, was unaffected by pre-absorption with anti-human IgM serum, but was neutralized by pre-absorption with anti-human IgG serum. These findings suggest that the cytotoxic activity of serum from patients with Hashimoto thyroiditis is due to the presence of thyroglobulin antibody of the IgG class in the form of complexes, either alone or with antigen.

It is postulated that non-specific lymphocytes may play an important role in the pathogenesis of Hashimoto thyroiditis, being activated by the presence in the gland of thyroglobulin antibody, either alone or in the form of complexes attached to thyroid cells.

Full text

PDF
154

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calder B. A., Penhale W. J., Barnes E. W., Irvine W. J. Cytotoxic lymphocytes in Hashimoto thyroiditis. An in vitro assay system using 51 Cr-labelled chicken red blood cells coated with thyroglobulin. Clin Exp Immunol. 1973 May;14(1):19–23. [PMC free article] [PubMed] [Google Scholar]
  2. Dumonde D. C., Wolstencroft R. A., Panayi G. S., Matthew M., Morley J., Howson W. T. "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969 Oct 4;224(5214):38–42. doi: 10.1038/224038a0. [DOI] [PubMed] [Google Scholar]
  3. Fakhri O., Hobbs J. R. Detection of antibodies which can cooperate with lymphocytes. Lancet. 1972 Aug 26;2(7774):403–406. doi: 10.1016/s0140-6736(72)91799-0. [DOI] [PubMed] [Google Scholar]
  4. Granger G. A., Kolb W. P. Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol. 1968 Jul;101(1):111–120. [PubMed] [Google Scholar]
  5. IRVINE W. J. The cytotoxic factor in thyroid disease. Scott Med J. 1960 Dec;5:511–522. doi: 10.1177/003693306000501202. [DOI] [PubMed] [Google Scholar]
  6. MacLennan I. C., Loewi G. Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature. 1968 Sep 7;219(5158):1069–1070. doi: 10.1038/2191069a0. [DOI] [PubMed] [Google Scholar]
  7. PULVERTAFT R. J., DONIACH D., ROITT I. M. The cytotoxic factor in Hashimoto's disease and its incidence in other thyroid diseases. Br J Exp Pathol. 1961 Oct;42:496–503. [PMC free article] [PubMed] [Google Scholar]
  8. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  9. Podleski W. K. Cytotoxic lymphocytes in Hashimoto's thyroiditis. Clin Exp Immunol. 1972 Aug;11(4):543–548. [PMC free article] [PubMed] [Google Scholar]
  10. Ringertz B., Wasserman J., Packalén T., Perlmann P. Cellular and humoral immune responses in experimental autoimmune thyroiditis. Int Arch Allergy Appl Immunol. 1971;40(6):917–927. doi: 10.1159/000230473. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES